BOT 1.47% 34.5¢ botanix pharmaceuticals ltd

new drug out soon

  1. 1,133 Posts.
    lightbulb Created with Sketch. 49


    Hi all
    Found this on the marketwatch site today

    BOSTON (MarketWatch) -- Shares of Merck /quotes/zigman/574389/quotes/nls/mrk MRK +4.13% jumped 4% in early trading Thursday, the day after it said it was ending a key Phase III clinical trial for its osteoporosis drug candidate odanacatib ahead of schedule because the drug had been shown to be highly effective. Merck said it plans to file for U.S., European and Japanese regulatory approval during the first half of 2013. Analysts at Citigroup upped their rating of Merck on Thursday to buy from neutral.

    How far along are we with our drug/s ???

    G.L.A.H

    Stu
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.